• 2017

    Started 2 Units for Injectables, Ointments and Nasal Drops. Established Presence in Germany.

  • 2016

    Started a new division for Veterinary APIs and Formulations.

  • 2014

    Started a new division for Nutraceutical Products.

  • 2012

    Started production at EU-GMP approved unit for solid dosage forms. Commenced registration of Finished Formulations in CIS countries and Latin America. Company's turnover crossed USD 25 million. Established presence in United Kingdom.

  • 2009

    Acquired new API Manufacturing Plant with purification technology.

  • 2008

    Company turnover crossed USD 10 Million.

  • 2007

    Started production of Anti-Malarial APIs at a new cGMP Unit.

  • 2006

    Began South East Asian operations in Thailand, Philippines, Hong Kong, Malaysia and Myanmar.

  • 2005

    Established presence in Latin America.

  • 2003

    Obtained WHO-GMP for manufacturing facilities and began production of Finished Formulations.

  • 2001

    Started production of APIs from advanced intermediates developed in-house.